Aridis Pharmaceuticals Valuation
| ARDS Stock | USD 0.0002 0 92.86% |
Aridis Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Aridis Pharmaceuticals from analyzing the firm fundamentals such as Return On Asset of -1.08, current valuation of 12.11 M, and Shares Owned By Insiders of 31.53 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Aridis Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Aridis Pharmaceuticals is based on 3 months time horizon. Increasing Aridis Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aridis pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Aridis Pharmaceuticals. Since Aridis Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aridis Pink Sheet. However, Aridis Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.92E-4 | Hype 1.98E-4 |
The intrinsic value of Aridis Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aridis Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aridis Pharmaceuticals helps investors to forecast how Aridis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aridis Pharmaceuticals more accurately as focusing exclusively on Aridis Pharmaceuticals' fundamentals will not take into account other important factors: About Aridis Pharmaceuticals Valuation
The pink sheet valuation mechanism determines Aridis Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aridis Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aridis Pharmaceuticals. We calculate exposure to Aridis Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aridis Pharmaceuticals's related companies.Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California. Aridis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
8 Steps to conduct Aridis Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aridis Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aridis Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Aridis Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Aridis Pharmaceuticals' revenue streams: Identify Aridis Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Aridis Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Aridis Pharmaceuticals' growth potential: Evaluate Aridis Pharmaceuticals' management, business model, and growth potential.
- Determine Aridis Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aridis Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Aridis Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aridis Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27 M | |
| Forward Price Earnings | 2.0606 |
Additional Tools for Aridis Pink Sheet Analysis
When running Aridis Pharmaceuticals' price analysis, check to measure Aridis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aridis Pharmaceuticals is operating at the current time. Most of Aridis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aridis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aridis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aridis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.